THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Maternal diet, excess bile acid and liver disease - Moms who eat a high-fat, high-sugar diet during pregnancy can increase ...

Researchers have found that stellate cells – known for their role in liver fibrosis – play a key role in protecting and ...

A fatty liver is the most common. Dr Sudeep Khanna, senior consultant, gastroenterology, Indraprastha Apollo Hospitals, ...

Researchers identify the Asah1 gene as a promising target for novel therapies to treat nonalcoholic fatty liver disease ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Almost one in three adults worldwide suffers from fatty liver disease, also known as metabolic dysfunction-associated fatty liver disease (MASLD). MASLD can lead to serious liver diseases such as ...

About 25% of NAFLD patients progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver fibrosis), which can lead to cirrhosis or even ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...